Reduced immunoreactivities of B-type natriuretic peptide in pulmonary arterial hypertension rats after ranolazine treatment-Reference-Cited by-同舟云学术

Reduced immunoreactivities of B-type natriuretic peptide in pulmonary arterial hypertension rats after ranolazine treatment

Published:2016 Issue:1 Volume:49 Page:7
ISSN:2093-3665
Container-title:Anatomy & Cell Biology
language:en
Short-container-title:Anat Cell Biol

Author:

Lee Jae Chul¹²³⁴,Kim Kwan Chang⁵,Choe Soo Young¹,Hong Young Mi⁴

Affiliation:

1. Department of Biology, School of Life Sciences, Chungbuk National University, Cheongju, Korea.

2. Department of Surgery, Brain Korea 21 PLUS Project for Medical Sciences and HBP Surgery and Liver Transplantation, Korea University College of Medicine, Seoul, Korea.

3. Department of Anatomy, Seoul National University College of Medicine, Seoul, Korea.

4. Department of Pediatrics, Ewha Womans University School of Medicine, Seoul, Korea.

5. Department of Thoracic and Cardiovascular Surgery, Ewha Womans University School of Medicine, Seoul, Korea.

Funder

Korea University

Publisher

Korean Association of Anatomists

Subject

Cell Biology,Cellular and Molecular Neuroscience,Developmental Biology,Histology,Anatomy

Link

http://synapse.koreamed.org/pdf/10.5115/acb.2016.49.1.7

Reference40 articles.

1. Ranolazine Reduces Remodeling of the Right Ventricle and Provoked Arrhythmias in Rats with Pulmonary Hypertension

2. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure

3. Emerging Concepts and Translational Priorities in Pulmonary Arterial Hypertension

4. Early detection of pulmonary arterial hypertension

5. The Need to Recognize the Pulmonary Circulation and the Right Ventricle as an Integrated Functional Unit: Facts and Hypotheses (2013 Grover Conference series)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Ligusticum Chuanxiong on Hypoxic Pulmonary Hypertension in Rats and Its Mechanism;Journal of Biosciences and Medicines;2022

2. Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning;Pharmaceuticals;2021-12-25

3. Herzrhythmusstörungen bei Patienten mit pulmonaler Hypertonie und Lungenerkrankungen;Herzschrittmachertherapie + Elektrophysiologie;2019-08-22

4. Prostaglandin E1 for preventing the progress of pulmonary arterial hypertension in rat model;Artery Research;2018

5. Therapeutic effect of prostaglandin E1 in monocrotaline-induced pulmonary arterial hypertension rats;Anatomy & Cell Biology;2017